- Supported exchanges /
- ST /
- MOB.ST
Moberg Pharma AB (publ) (MOB ST) stock market data APIs
kr19.61
1.35(7.4%)
as of November 22, 2024
Price chart is built with Anychart
Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It develops MOB-015, which has completed Phase III clinical trial for the treatment of nail fungus. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. Moberg Pharma AB (publ) was incorporated in 2006 and is headquartered in Bromma, Sweden.
Moberg Pharma AB (publ) Financial Data Overview
| 17.99 | |
| 19.61 | |
| - | |
| 19.96 | |
| 17.79 | |
| 9.375-40.9 | |
| 742 M | |
| 46 693 K | |
| 4 929 K | |
| -0.027 | |
| 0.778 |
Our easy-to-use no-coding solutions help you get the data effortlessly:
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
General: {
Code:
'MOB',
Type:
'Common Stock',
Name:
'Moberg Pharma AB (publ)',
Exchange:
'ST',
CurrencyCode:
'SEK',
CurrencyName:
'Swedish krone',
CurrencySymbol:
'kr',
CountryName:
'Sweden',
CountryISO:
'SE',
OpenFigi:
NULL,
ISIN:
'SE0003613090',
CIK:
NULL,
EmployerIdNumber:
NULL,
FiscalYearEnd:
'December',
IPODate:
NULL,
InternationalDomestic:
NULL,
Sector:
'Healthcare',
Industry:
'Drug Manufacturers - Specialty & Generic',
}
Moberg Pharma AB (publ) Fundamental Data is available in our Financial Data APIs
- Net Revenue 4 929 K
- EBITDA -29 123 334
- Earnings Per Share -0.79
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Moberg Pharma AB (publ) Earnings via APIs
- Latest Release 2024-11-12
- EPS/Forecast NaN
Get Moberg Pharma AB (publ) End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Do you have any questions?
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
